HER2-POSITIVE BREAST CARCINOMA
Clinical trials for HER2-POSITIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2-POSITIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2-POSITIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo trial for aggressive breast cancer halted early
Disease control TerminatedThis study looked at adding a drug called copanlisib to standard targeted therapy (trastuzumab and pertuzumab) for people with advanced HER2-positive breast cancer that has a specific genetic change (PIK3CA or PTEN mutation). The goal was to see if the combination could shrink tu…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Can a gut pill stop chemo stomach woes? trial tests rifaximin for breast cancer patients
Symptom relief TerminatedThis study tested the antibiotic rifaximin in 20 people with early-stage HER2-positive breast cancer who had stomach problems from pertuzumab-based chemotherapy. The goal was to see if rifaximin could reduce side effects like diarrhea and belly pain, helping patients stay on thei…
Matched conditions: HER2-POSITIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 17, 2026 05:47 UTC